Skip to main content

Opioid Analgesics and Opioid Antagonists

  • Chapter
Opioid Dependence
  • 84 Accesses

Abstract

By opioid is meant any drug, regardless of chemical structure, that acts like morphine. The term opioid is preferred to the older term, opiate, for two reasons: first, because opiate implies presence in or derivation from opium, which indeed contains the analgesic drugs morphine and codeine but also contains thebaine, a strong stimulant (convulsive) drug with minimal analgesic properties, and also papaverine and noscapine, which have no analgesic actions; and second, because of a host of purely synthetic drugs with actions qualitatively similar to those of morphine and codeine that, unlike the analgesics found in opium or derived therefrom, lack the phenanthrene nucleus (e.g., methadone, meperidine, d-propoxyphene). Opium is prepared from the sap of the poppy Papaver somniferum and contains about 10% by weight of morphine and about 0.5% by weight of codeine. Analgesic compounds that are derived from morphine and that retain the phenanthrene nucleus and are classed as opioids include heroin (diacetylmorphine), hydromorphone (Dilaudid), oxymorphone (Numorphan), and oxycodone (Percodan). Purely synthetic analgesic compounds that lack the phenanthrene nucleus but are classed as opioids include methadone (Dolophine), meperidine (Demerol), d-propoxyphene (Darvon), levorphanol (Levo-Dromoran), and phenazocine (Prinadol). In man, the analgesic potencies of these drugs relative to morphine (all drugs given subcutaneously) are codeine, one-twelfth; heroin, 2–3 times; hydromorphine, 6–8 times; oxymorphone, 7–10 times; oxycodone, two-thirds to equipotent; methadone, equipotent; meperidine, one-tenth to one-eighth; levorphanol, 2–3 times; and phenazocine, 3 times. By the oral route, 65 mg of d-propoxyphene is equivalent to 32–45 mg of codeine for analgesia, but 32 mg of d-propoxyphene may be no more effective than placebo. A newer synthetic compound, pentazocine (Talwin), exerts some morphinelike effects (analgesia, respiratory depression, sedation) in doses of 30–50 mg given parenterally (equivalent to 10 mg of morphine) or of 50 mg given orally (equivalent to 60 mg of codeine); at higher doses, pentazocine also produces dysphoric and psychotomimetic effects that can be reversed by naloxone, but not by nalorphine. In addition, pentazocine has weak opioid-antagonistic actions and can precipitate abstinence phenomena in morphine-dependent individuals. Though not in clinical use, etorphine (Immobilon), an opioid derived from oripavine and ultimately from thebaine, is of interest because of its extreme potency. In man, it is about 400 times as potent as morphine, though its duration of action is much shorter; in animals, its potency is even greater than in man, and it is used for immobilizing large game animals (Harthoorn & Bligh, 1965). Although of all these opioid analgesics, heroin is the most widely abused in the United States, its pharmacological effects (including the development of tolerance and physical dependence) do not differ qualitatively from those of morphine. The same is true also of hydromorphone, oxymorphone, oxycodone, levorphanol, phenazocine, and methadone, but the pharmacological effects of meperidine, d-propoxyphene, and pentazocine present more prominent differences with regard to “toxicity” and/or physical dependence. The pharmacological effects of morphine serve here as a prototype of the actions of opioids in general, and deviations from this prototype are noted for some particular opioid analgesics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen, C. R., Murphy, M. A., and Meek, W. J., 1945, The action of morphine in slowing the heart rate of unconditioned dogs, Anesthesiology 6: 149–153.

    CAS  Google Scholar 

  • Andrews, H. L., 1943, Changes in the electroencephalogram during a cycle of morphine addiction, Psychosom. Med. 5: 143–147.

    Google Scholar 

  • Andrews, H. L., and Himmelsbach, C. K., 1944, Relation to the intensity of the morphine abstinence syndrome to dosage, J. Pharmacol. Exp. Ther. 81: 288–293.

    CAS  Google Scholar 

  • Andrews, H. L., and Workman, W., 1941, Pain threshold measurements in the dog, J. Pharmacol. Exp. Ther. 73: 99–103.

    CAS  Google Scholar 

  • Archer, S., Albertson, N. F., Harris, L. S., Pierson, A. K., Bird, J. G., Keats, A. S., Telford, J., and Papadopoulos, C. N., 1962, Narcotic antagonists as analgesics, Science 137: 541–543.

    Google Scholar 

  • Archer, S., Albertson, N. F., Harris, L. S., Pierson, A. K., and Bird, J. G., 1964, Pentazocine: Strong analgesics and analgesic antagonists in the benzomorphan series, J. Med. Chem. 7: 123–127.

    PubMed  CAS  Google Scholar 

  • Arduini, A., and Arduini, M. G., 1954, Effect of drugs and metabolic alterations on brain stem arousal mechanism, J. Pharmacol. Exp. Ther. 110: 76–85.

    PubMed  CAS  Google Scholar 

  • Bauer, R. O., and Pearson, R. G., 1956, The effects of morphine-nalorphine mixtures on psychmotor performance, J. Pharmacol. Exp. Ther., 117: 258–264.

    PubMed  CAS  Google Scholar 

  • Bickerman, A. A., and Barach, A. L., 1954, The experimental production of cough in human subjects induced by citric acid aerosis: Preliminary studies on the evaluation of antitussive agents, Amer. J. Med. Sci. 228: 156–163.

    PubMed  CAS  Google Scholar 

  • Blumberg, H., and Dayton, H. B., 1972, Narcotic antagonist studies with EN-1639A (Ncyclopropylmethylnoroxymorphone hydrochloride), in Fifth International Congress on Pharmacology, San Francisco, 23–28 July 1972, Abstracts of Volunteer Papers, p. 23.

    Google Scholar 

  • Blumberg, H., Dayton, H. B., George, M., and Rapaport, D. N., 1961, N-allylnoroxymorphone: A potent narcotic antagonist, Fed. Proc. 20: 311.

    Google Scholar 

  • Bremer, F., 1937, Différence d’action de la narcose éthérique et du sommeil barbiturique sur les réactions sensorielles acoustiques du cortex cérébral: Signification de cette différence en ce qui concerne la mécanisme du sommeil, Compt. Rend. Soc. Biol. Paris 124: 848–852.

    Google Scholar 

  • Briggs, F. N., and Munson, P. L., 1954, Suppression of the release of adrenocortictrophic hormone (ACTH) my morphine, J. Pharmacol. Exp. Ther. 110: 7–8.

    Google Scholar 

  • Brooks, C. McC., and Peck, M. E., 1940, Effect of various cortical lesions on development of placing and hopping reactions in rats, J. Neurophysiol. 3: 66–72.

    Google Scholar 

  • Brooks, C. McC., Goodwin, R., and Willard, H. N., 1941, The effect of various brain lesions on morphine induced hyperglycemia and excitement in the cat, Amer. J. Physiol. (Proc.) 133: 226–227.

    Google Scholar 

  • CoTui, F. W., DeBodo, R. C., and Bengalia, A. E., 1937, Morphine Hyperglycemia, J. Pharmacol. Exp. Ther. 61: 48–57.

    Google Scholar 

  • D’Amour, F. E., and Smith, D. L., 1941, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72: 74–79.

    Google Scholar 

  • DeBodo, R. C., 1944, The antidiuretic of morphine and its mechanism, J. Pharmacol. Exp. Ther. 82: 74–85.

    CAS  Google Scholar 

  • DeBodo, R. C., and Brooks, C. McC., 1937, The effects of morphine on blood sugar and reflex activity in the chronic spinal cat, J. Pharmacol. Exp. Ther. 61: 82–88.

    Google Scholar 

  • De Noraquo, N., 1969, The hallucinatory effect of pentazocine (Talwin), J. Amer. Med. Ass. 210: 502.

    Google Scholar 

  • Drew, J. H., Dripps, R. D., and Comroe, J. H., 1946, Clinical studies on morphine. II. The effect of morphine upon the circulation of man and upon the circulatory and respiratory responses to tilting, Anesthesiology 7: 4–61.

    Google Scholar 

  • Dripps, R. B., and Dumke, P. R., 1943, The effect of narcotics on the balance between central and chemoreceptor control of respiration, J. Pharmacol. Exp. Ther. 77: 290–300.

    CAS  Google Scholar 

  • Drug and Theraputic Information, Inc. (New York), 1970, Propoxyphene hydrochloride (Darvon) and Darvon compounds, The Medical Letter 12(2), Jan. 23.

    Google Scholar 

  • Eckenoff, J. E., Elder, J. D., and King, B. D., 1951, The effect of N-allylnormorphine in treatment of opiate overdose, Amer. J. Med. Sci. 222: 115–117.

    Google Scholar 

  • Eckenhoff, J. E., Elder, J. D., and King, B. D., 1952, N-allylnormorphine in the treatment of morphine or Demerol narcosis, Amer. J. Med. Sci. 223: 191–197.

    PubMed  CAS  Google Scholar 

  • Eddy, N. B., and May, E. L., 1973, The search for a better analgesic, Science 181: 407–414.

    PubMed  CAS  Google Scholar 

  • Eisenman, A. J., Fraser, H. F., and Brooks, J. W., 1961, Urinary excretion and plasma levels of 17-hydroxycorticosteroids during a cycle of addiction to morphine, J. Pharmacol. Exp. Ther. 132: 226–231.

    PubMed  CAS  Google Scholar 

  • Eisenman, A. J., Sloan, J. W., Martin, W. R., Jasinski, D. R., and Brooks, J. W., 1969, Catecholamine and 17-hydroxycorico-steroid excretion during a cycle of morphine dependence in man, J. Psychiat. Res. 7: 19–28.

    PubMed  CAS  Google Scholar 

  • Fischlewitz, J., 1948, Über den Angriffspunkt des Morphins am Atmungszentrum, Helv. Physiol. Acta. 6: 455–461.

    CAS  Google Scholar 

  • Foldes, F. F., Lunn, J. N., Moore, J., and Brown, I. M., 1963, N-allylnoroxymorphone: A new potent narcotic antagonist, Amer. J. Med. Sci. 245: 23–30.

    PubMed  CAS  Google Scholar 

  • Food and Drug Administration, Pentazocine abuse rises—Schedule IV status proposed, 1978–1979, FDA Drug Bull. 8(6):34.

    Google Scholar 

  • Food and Drug Administration, 1979, Fatalities due to propoxyphene, FDA Drug Bull. 9 (1): 2.

    Google Scholar 

  • Fraser, H. F., and Isbell, H., 1952, Comparative effects of 20 mg., of morphine sulfate on non-addicts and former addicts, J. Pharmacol. Exp. Ther. 105: 498–502.

    PubMed  CAS  Google Scholar 

  • Fraser, H. F., and Isbell, H., 1960, Human pharmacology and addiction liability of dl - and d-propoxyphene, U. N. Bull. Narcotics 12: 9–14.

    CAS  Google Scholar 

  • Fraser, H. F., and Rosenberg, D. E., 1964, Studies of human addiction liability of 2’hydroxy-5, 9-dimethy-2-(3,3-dimethylallyl)-6,7-benzomorphan (WIN 20,228): Weak narcotic antagonist, J. Pharmacol. Exper. Ther, 143: 149–156.

    CAS  Google Scholar 

  • Fraser, H. F., Wikler, A., Eiseman, A. J., and Isbell, H., 1952, Use of N-allylnormorphine in treatment of methadone poisoning in man: Report of two cases, J. Amer. Med. Ass. 148: 1205–1207.

    CAS  Google Scholar 

  • Fraser, H. F., Nash, T. L., Van Horn, G. D., and Isbell, H., 1954, Use of miotic effect in evaluating analgesic drugs in man, Arch. Int. Pharmacodyn. Ther. 98: 443–451.

    PubMed  CAS  Google Scholar 

  • Fraser, H. F., Van Horn, G. D., and Isbell, H., 1956, Studies on N-allylnormorphine in man: Antagonism to morphine and heroin and effects of mixtures of N-allylnormorphine and morphine, Amer. J. Med. Sci. 231: 1–8.

    PubMed  CAS  Google Scholar 

  • Fraser, H. F., Isbell, H., and Van Horn, G. D., 1957, Effects of morphine as compared with a mixture of morphine and diaminphenylthiazole (Daptazole), Anesthesiology 18: 53 1535.

    Google Scholar 

  • Fraser, H. F., Van Horn, G. D., Martin, W. R., Wolbach, A. B., and Isbell, H., 1961, Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs. (B) A short-term “direct” addiction test, J. Pharmacol. Exp. mer. 133: 371–387.

    CAS  Google Scholar 

  • George, R., and Way, E. L., 1955a, Adrenal cortical response of normal, adrenal demedullated and hypophysectomized rats to morphine and methadone, J. Pharmacol. Exp. Ther. 113: 23.

    Google Scholar 

  • George, R., and Way, E. L., 1955b, Studies on the mechanism of pituitary-adrenal activation by morphine, Brit. J. Pharmacol. Chemother. 20: 260–264.

    Google Scholar 

  • George, R., and Way, E. L., 1959, The role of the hypothalamus in pituitary-adrenal activation and antidiuresis by morphine, J. Pharmacol. Exp. Ther. 125: 111–115.

    PubMed  CAS  Google Scholar 

  • Goetz, E. L., and Bain, R. V., 1974, Neonatal withdrawal symptoms associated with maternal use of pentazocine, J. Pediatr. 84: 887–888.

    PubMed  CAS  Google Scholar 

  • Gray, G. W., and Beckman, H., 1956, Effects of certain analgesic and analgesic-antagonist drugs on intestinal motility, J. Pharmacol. Exp. Ther. 116: 25.

    Google Scholar 

  • Haertzen, C. A., and Hooks, N. T., 1969, Changes in personality and subjective experience associate with the chronic administration of opiates, J. Nerv. Ment. Dis. 148: 606–614.

    PubMed  CAS  Google Scholar 

  • Hambourger, W. E., 1940, The excitant action of morphine on the cat, J. Pharmacol. Exp. Ther. (Abstract) 69: 287.

    Google Scholar 

  • Harris, L. S., and Pierson, A. K., 1964, Some narcotic antagonists in the benzomorphan series, J. Pharmacol. Exp. Ther. 143: 141–148.

    PubMed  CAS  Google Scholar 

  • Harthoorn, A. M., and Bligh, J., 1965, The use of a new oripavine derivative with potent morphine-like activity for the restraint of hoofed wild animals, Res. Vet. Sci.6: 290–299.

    Google Scholar 

  • Hemingway, A., 1938, The effect of morphine on the skin and rectal temperatures of dogs as related to thermal polypnea, J. Pharmacol. Exp. Ther. 63: 414–420.

    CAS  Google Scholar 

  • Henderson, V. W., and Rice, H. V., 1939, The action of certain drugs on respiratory reflexes, J. Pharmacol. Exp. Ther. 66: 336–349.

    CAS  Google Scholar 

  • Himmelsbach, C. K., 1941, Studies on the relation of drug addiction to the autonomic nervous system: Results of cold pressor tests, J. Pharmacol. Exp. Ther. 73: 91–97.

    CAS  Google Scholar 

  • Himmelsbach, C. K., 1942a, Clinical studies on drug addiction. Physical dependence, withdrawal and recovery, Arch. Int. Med. 69: 766–722.

    Google Scholar 

  • Himmelsbach, C. K., 1942b, Studies of the addiction liability of “Demerol” (D-140), J. Pharmacol. Exp. Ther. 75: 54–68.

    Google Scholar 

  • Himmelsbach, C. K., 1943, Further studies of the addiction liability of Demerol (1methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester hydrochloride), J. Pharmacol. Exp. Ther. 79: 5–9.

    CAS  Google Scholar 

  • Himmelsbach, C. K., 1944, Studies on the relation of drug addiction to the autonomic nervous system: results of tests of peripheral blood flow, J. Pharmacol. Exp. Ther. 80: 343–353.

    CAS  Google Scholar 

  • Himmelsbach, C. K., Andrews, H. L., Felix, R. H., Oberst, F. W., and Davenport, L., 1940, Studies on codeine addiction, Publ. Health Rep. Suppl. 158.

    Google Scholar 

  • Houde, R. R., and Wikler, A., 1951, Delineation of the skin-twitch response in dogs and the effects thereon on morphine, theiopental and mephenesin, J. Pharmacol. Exp. Ther. 103: 236–242, 1951.

    PubMed  CAS  Google Scholar 

  • Huggins, R. A., Handley, C. A., and La Forge, M., 1949, Effects of morphine, codiene and dilaudid on blood flow, J. Pharmacol. Exp. Ther. 95: 318–322.

    PubMed  CAS  Google Scholar 

  • Irwin, S., Houde, R. W., Bennett, D. R., Hendershot, L. C., and Seevers, M. H., 1951, The effects of morphine, methadone, and meperidine on some reflex responses of spinal animals to nociceptive stimulation, J. Pharmacol. Exp. Ther. 101: 132–143.

    PubMed  CAS  Google Scholar 

  • Isbell, H., 1947, Effect of morphine addiction on blood, plasma and “extracellular” fluid volumes in man, Pub. Health Reports 62: 1499–1513.

    CAS  Google Scholar 

  • Isbell, H., 1956, Attempted addiction to nalorphine, Fed. Proc. 15: 442.

    Google Scholar 

  • Isbell, H., Eisenman, A. J., Wikler, A., and Frank, K., 1948a, The effects of single doses of 6-dimethylamino-4, 4-diphenyl-3-heptanone (Amidon, methadon, or “10820”) on human subjects, J. Pharmacol. Exp. Ther. 92: 83–89.

    PubMed  CAS  Google Scholar 

  • Isbell, H., Wikler, A., Eisenman, A. J., Daingerfield, M., and Frank, K., 1948b, Liability of addiction of 6-dimethylamino-4, 4-diphenyl-3-heptanone (methodon, amidone or “10820”) in man, Arch. Int. Med. 82: 362–396.

    CAS  Google Scholar 

  • Jasinski, D. R., 1973, Assessment of the dependence liability of opiates and sedative hypnotics, in Psychic Dependence ( L. Goldberg and F. Hoffmeister, Eds.), p. 164. Springer-Verlag, New York.

    Google Scholar 

  • Jasinski, D. R., Martin, W. R., and Haertzen, C. A., 1967, The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone), J. Pharmacol. Exp. Ther. 157: 420–426.

    PubMed  CAS  Google Scholar 

  • Karliner, J. S., 1967, Propoxyphene hydrochloride poisoning: Report of a case treated with peritoneal dialysis, J. Amer. Ass. 199: 1006–1009.

    Google Scholar 

  • Kay, D. C., 1975a, Human sleep and EEG through a cycle of methadone dependence, Electroenceph. Clin. Neurophysiol. 38: 35–43.

    PubMed  CAS  Google Scholar 

  • Kay, D. C., 1975b, Human sleep during chronic morphine intoxication, Psychopharmacologia 44: 117–124.

    PubMed  CAS  Google Scholar 

  • Kay, D. C., Eisenstein, R. B., and Jasinski, D. R., 1949, Morphine effects on human REM state, waking state and NREM sleep, Psychopharmacologia 14: 404–416.

    Google Scholar 

  • Keats, A. S., and Telford, J., 1956, Nalorphine, a potent analgesic in man, J. Pharmacol. Exp. Ther. 117: 190–196.

    PubMed  CAS  Google Scholar 

  • Lasagna, L., 1965, Drug interaction in the field of analgesic drugs, Proc. Roy. Soc. Med. 58: 978–983.

    PubMed  CAS  Google Scholar 

  • Lasagna, L., and Beecher, H. K., 1954, The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man, J. Pharmacol. Exp. Ther. 112: 356–363.

    PubMed  CAS  Google Scholar 

  • Lee, H. K., and Wang, S. C., 1975, Mechanism of morphine-induced miosis in the dog, J. Pharmacol. Exp. Ther. 192: 415–431.

    PubMed  CAS  Google Scholar 

  • Leimdorfer, A., 1948, An electroencephalographic analysis of the action of amidone, morphine and strychnine on the central nervous system. Arch. Int. Pharmacodyn. Ther. 76: 153–162.

    PubMed  CAS  Google Scholar 

  • Lindsley, D. B., Bowden, J. W., and Magoun, H. W., 1949, Effect upon the EEG of acute injury to the brain stem activating mechanism, Electroencephalog. Clin. Neurophysiol. 1: 475–485.

    Google Scholar 

  • Lotti, V. J., Lomax, P., and George, R., 1965a, N-allylnormorphine antagonism of the hypothermic effect of morphine in the rat following intracerebral and systemic administration, J. Pharmacol. Exp. Ther. 150: 420–425.

    PubMed  CAS  Google Scholar 

  • Lotti, V. J., Lomax, P., and George, R., 1965b, Temperature responses in the rat following intracerebral microinjection of morphine, J. Pharmacol. Exp. Ther. 150: 135–139.

    PubMed  CAS  Google Scholar 

  • Lotti, V. J., Lomax, P., and George, R., 1966, Acute tolerance to morphine following systemic and intracerebral injection in the rat, Int. J. Neuropharmacol. 5: 35–42.

    PubMed  CAS  Google Scholar 

  • Lotti, V. J., Kokka, N., and George, R., 1969, Pituitary-adrenal activation following intrahypothalamic microinjection of morphine, Neuroendocrinology 4: 326–332.

    PubMed  CAS  Google Scholar 

  • Marri, R., and Hauss, W. H., 1939, Sinus carotidien et réflexes respiratoires: Influences de l’hypoxemie, de l’hypercapnie, de la saignée, de l’hyperthermie, de l’ésérine, de la morphine, du véronal et de l’évipan sur les réflexes respiratoires déclenchés par les variations de la pression sanguine au niveau du sinus carotidien, Arch. Int. Pharmacodyn. Thér. 63: 449–469.

    CAS  Google Scholar 

  • Martin, W. R., 1967, Opioid antagonists, Pharmacol. Rev. 19: 463–521.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., and Fraser, H. F., 1961, A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in post-addicts, J. Pharmacol. Exp. Ther. 133: 388–399.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., and Gorodetzky, C. W., 1965, Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine), J. Pharmacol. Exp. Ther. 150: 437–442.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., and Jasinski, D. R., 1969, Physiological parameters of morphine dependence in man: Tolerance, early abstinence, protracted abstinence, J. Psychiat. Res. 7: 9–17.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., Wilder, A., Eades, C. G., and Pescor, F. R., 1963, Tolerance to and physical dependence on morphine in the rat, Psychopharmacologia 4: 247–260.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., Fraser, H. F., Gorodetzky, C. W., and Rosenberg, D. E., 1965, Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl2’-hydroxy-5, 9-dimethyl-6, 7 benzomorphan (cyclazocine, WIN-20, 740, ARC II-C-3), J. Pharmacol. Exp. Ther. 150: 426–436.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., Gorodetzky, C. W., and McClane, T. K., 1966, An experimental study in the treatment of narcotic addicts with cyclazocine, Clin. Pharmacol. Ther. 7: 455–465.

    PubMed  CAS  Google Scholar 

  • Martin, W. R., Jasinski, D. R., Sapira, J. D., Flanary, H. G., Kelly, O. A., Thompson, A. K., and Logan, C. R., 1968, The respiratory effects of morphine during a cycle of dependence, J. Pharmacol. Exp. Ther. 62: 182–189.

    Google Scholar 

  • Martin, W. R., Jasinski, D. R., and Mansky, P. A., 1973, Naltrexone, an antagonist for the treatment of heroin dependence, Arch. Gen. Psychiat. 28: 784–791.

    PubMed  CAS  Google Scholar 

  • Masserman, J. H. 1939, Effects of morphine sulfate on hypothalamus of cat, Proc. Soc. Exp. Biol. Med. (N.Y.) 42:315–317.

    Google Scholar 

  • McCawley, E. L., Hart, E. R., and Marsh, D. F., 1941, The preparation of N-allylnormorphine, J. Amer. Chem. Soc. 63: 314.

    CAS  Google Scholar 

  • McCrea, F. D., Eadie, G. S., and Morgan, J. E., 1942, The mechanism of morphine miosis, J. Pharmacol. Exp. Ther. 74: 239–246.

    CAS  Google Scholar 

  • Meissner, R. 1923, Ueber atmungserregende Heilmittel, Z. gesamte Exp. Med. 31: 159–214.

    Google Scholar 

  • Nilsen, O. L., 1961, Studies on algesimetry by electrical stimulation of the mouse tail, Acta Pharmacol. Toxicol. 18: 10–22.

    CAS  Google Scholar 

  • Orahovats, P. D., Winter, C. A., and Lehman, E. G., 1953, The effect of N-allylnormorphine upon the development of tolerance to morphine in the albino rat, J. Pharmacol. Exp. Ther. 109: 413–416.

    PubMed  CAS  Google Scholar 

  • Pearl, J., Stander, H., and McKean, D. B., 1969, Effects of analgesics and other drugs on mice in phenylquinone and rotarod tests, J. Pharmacol. Exp. Ther. 167: 9–13.

    PubMed  CAS  Google Scholar 

  • Perrine, T. D., Atwell, L., Tice, I. B., Jacobson, A. E., and May, E. L., 1972, Analgesic activity as determined by the Nilsen method, J. Pharm. Sci. 61: 86–88.

    PubMed  CAS  Google Scholar 

  • Pohl, J., 1915, Ober das N-allylnorcodein, einen Antagonisten des Morphins, Z. exp. Path. Ther. 17: 370–382.

    Google Scholar 

  • Richter, C. P., and Paterson, A. S., 1932, On the pharmacology of the grasp reflex, Brain 55: 391–396.

    Google Scholar 

  • Rovenstine, E. A., and Cullen, S. C., 1939, Anesthetic management of patients with hyperactive carotid sinus reflex, Surgery 6: 167–176.

    Google Scholar 

  • Sandoval, R. G., and Wang, R. I. H., 1969, Tolerance and dependence on pentazocine, New Engl. J. Med. 280: 1391–1392.

    PubMed  CAS  Google Scholar 

  • Sawyer, C. H., Critchlow, B. V., and Barraclough, C. A., 1955, Mechanisms of blockage of pituitary activation in the rat by morphine, atropine and barbiturates, Endocrinology 57: 345–354.

    Google Scholar 

  • Scanlon, J. W., 1974, Pentazocine and neonatal withdrawal symptoms, J. Pediatr. 85: 735–736.

    PubMed  CAS  Google Scholar 

  • Schmidt, C. F., 1940, Effect of carotid sinus and carotid body reflexes upon respiration, Anesthesiol. Analgesia 19: 261–271.

    Google Scholar 

  • Schrappe, 0., 1959, “Physical dependence” nach chronischer Verabreichung von N-allylnormorphin, Arzneim. -Forsch. 9:130–132.

    Google Scholar 

  • Seevers, M. H., and Deneau, G. A., 1963, Physiological aspects of tolerance and physical dependence, in Physiological Pharmacology, Vol. 1 ( W. S. Root and F. G. Hofmann, Eds.), pp. 565–640. Academic Press, New York.

    Google Scholar 

  • Seevers, M. H., and Woods, L. A., 1953, The phenomena of tolerance, Amer. J. Med. 14: 546–557.

    CAS  Google Scholar 

  • Sharpe, L. G., and Pickworth, W. B., 1980, Pharmacologic evidence for a tonic muscarinic inhibitory input to the Edinger-Westphal nucleus: Relation to morphine-induced miosis in the dog. (in preparation).

    Google Scholar 

  • Silvestrini, B. and Longo, V. G., 1956, Selective activity of morphine on the ‘BEG arousal reaction“ to painful stimul, Experientia 12:436–438.

    Google Scholar 

  • Smith, G. M., and Beecher, H. K., 1959, Measurement of “mental clouding” and other subjective effects of morphine, J. Pharmacol. Exp. Ther. 126: 50–62.

    PubMed  CAS  Google Scholar 

  • Smith, G. M., Semke, C. W., and Beecher, H. K., 1962, Objective evidence of mental effects of heroin, morphine and placebo in normal subjects, J. Pharmacol. Exp. Ther. 136: 53–58.

    PubMed  CAS  Google Scholar 

  • Tainter, N. L., Tainter, E. G., Lawrence, W. A., Neura, E. N., Lackey, R. W., Ludnea, F. P., Kirland, H. B., and Gonzale, R. I., 1943, Influence of various drugs on the threshold for electrical convulsions, J. Pharmacol. Exp. Ther. 79: 42–53.

    Google Scholar 

  • Tenney, S. M., and Mithoefer, J. C., 1953, The respiratory depressant action of N-allylnormorphine in the normal subject and in patients with respiratory acidosis secondary to pulmonary emphysema, New Engl. J. Med. 249: 886–890.

    PubMed  CAS  Google Scholar 

  • Wang, S. C., and Glaviano, V. V., 1954, Locus of emetic action of morphine and hydergine in dogs, J. Pharmacol. Exp. Ther. 111: 329–334.

    PubMed  CAS  Google Scholar 

  • Weijlard, J., and Erickson, A. E., 1942, N-allylnormorphine, J. Amer. Chem. Soc. 64: 869–870.

    CAS  Google Scholar 

  • Wikler, A., 1944, Studies on the action of morphine on the central nervous system of the cat, J. Pharmacol. Exp. Ther. 80: 176–187.

    CAS  Google Scholar 

  • Wikler, A., 1950, Sites and mechanisms of action of morphine and related drugs in the central nervous system, Pharmacol. Rev. 2: 435–506.

    Google Scholar 

  • Wikler, A., 1951, Effects of large doses of N-allylnormorphine in man, Fed. Proc. 10: 345.

    Google Scholar 

  • Wikler, A., 1952a, A psychodynamic study of a patient during self-regulated re-addiction to morphine, Psychiat. Quart. 260: 270–293.

    Google Scholar 

  • Wikler, A., 1952b, Reactions of dogs without neocortex during cycles of addiction to morphine and methadone, Arch. Neurol. Psychiat. (Chicago) 67: 672–684.

    CAS  Google Scholar 

  • Wikler, A., 1953, Opiate Addiction: Psychological and Neurophysiological Aspects in Relation to Clinical Problems, pp. 27–28. Charles C Thomas, Springfield, Ill.

    Google Scholar 

  • Wikler, A., 1954, Clinical and electroencephalographic studies on the effects of mescaline, N-allylnormorphine and morphine in man, J. Nero. Ment. Dis. 120: 157–175.

    CAS  Google Scholar 

  • Wikler, A., and Altschul, S., 1950, Effects of methadone and morphine on the electroencephalogram of the dog, J. Pharmacol. Exp. Ther. 98: 437–446.

    PubMed  CAS  Google Scholar 

  • Wikler, A., and Carter, R. L., 1953, Effects of single doses of N-allylnormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction, J. Pharmacol. Exp. Ther. 109: 92–101.

    PubMed  CAS  Google Scholar 

  • Wikler, A., and Pescor, F. T., 1954, Clinical and electroencephalographic effects of drugs in man and dog, Trans. Amer. Neurol. Ass. 79th Annual Meeting, pp. 170–172.

    Google Scholar 

  • Wikler, A., Pescor, M. J., Kalbaugh, E. M., and Angelucci, R. J., 1952, The effects of frontal lobotomy on the morphine abstinence syndrome in man: An experimental study, Arch. Neurol. Psychiat. (Chicago) 67: 510–521.

    CAS  Google Scholar 

  • Wikler, A., Fraser, H. F., and Isbell, H., 1953, N-allylnormorphine: Effects of single doses and precipitation of acute “abstinence syndromes” during addiction to morphine, methadone or heroin in man (post-addicts), J. Pharmacol. Exp. Ther. 109: 8–20.

    Google Scholar 

  • Williams, E. G., and Oberst, F. W., 1946, A cycle of morphine addiction. Part I. Biological investigations, Pub. Health Reports 61: 1–25.

    CAS  Google Scholar 

  • Winter, C. A., and Flataker, L., 1951, The effect of cortisone, desoxycorticosterone and adrenocorticotrophic hormone upon the responses of animals to analgesic drugs, J. Pharmacol. Exp. Ther. 103: 93–105.

    PubMed  CAS  Google Scholar 

  • Woods, L. A., 1956, The pharmacology of nalorphine (N-allylnormorphine), Pharmacol. Rev. 8: 175–198.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Plenum Press, New York

About this chapter

Cite this chapter

Wikler, A. (1980). Opioid Analgesics and Opioid Antagonists. In: Opioid Dependence. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3866-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3866-6_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3868-0

  • Online ISBN: 978-1-4684-3866-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics